We've found
33,560
archived clinical trials in
Neurology
We've found
33,560
archived clinical trials in
Neurology
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Updated: 3/27/2009
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Updated: 3/27/2009
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Updated: 3/27/2009
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Updated: 3/27/2009
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Updated: 3/27/2009
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Updated: 3/27/2009
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Updated: 3/27/2009
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Updated: 3/27/2009
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Updated: 3/27/2009
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Updated: 3/27/2009
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Updated: 3/27/2009
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Updated: 3/27/2009
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Updated: 3/27/2009
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Updated: 3/27/2009
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
Click here to add this to my saved trials
Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder
Updated: 4/8/2009
Organizational Skills Treatment for ADHD Children
Status: Enrolling
Updated: 4/8/2009
Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder
Updated: 4/8/2009
Organizational Skills Treatment for ADHD Children
Status: Enrolling
Updated: 4/8/2009
Click here to add this to my saved trials
Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder
Updated: 4/8/2009
Organizational Skills Treatment for ADHD Children
Status: Enrolling
Updated: 4/8/2009
Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder
Updated: 4/8/2009
Organizational Skills Treatment for ADHD Children
Status: Enrolling
Updated: 4/8/2009
Click here to add this to my saved trials
Long-Term Olanzapine Treatment in Children With Autism
Updated: 4/29/2009
Long-Term Olanzapine Treatment in Children With Autism
Status: Enrolling
Updated: 4/29/2009
Long-Term Olanzapine Treatment in Children With Autism
Updated: 4/29/2009
Long-Term Olanzapine Treatment in Children With Autism
Status: Enrolling
Updated: 4/29/2009
Click here to add this to my saved trials
Cryptogenic Stroke Study
Updated: 5/4/2009
Long-Term Cardiac Monitoring for Detection of Atrial Fibrillation After Cryptogenic Stroke
Status: Enrolling
Updated: 5/4/2009
Cryptogenic Stroke Study
Updated: 5/4/2009
Long-Term Cardiac Monitoring for Detection of Atrial Fibrillation After Cryptogenic Stroke
Status: Enrolling
Updated: 5/4/2009
Click here to add this to my saved trials
The Effects of Exercise Versus Inactivity on People With Mitochondrial Muscle Disease
Updated: 5/18/2009
Exercise Training and Deconditions: Implications for Therapy in Mitochondrial Myopathy
Status: Enrolling
Updated: 5/18/2009
The Effects of Exercise Versus Inactivity on People With Mitochondrial Muscle Disease
Updated: 5/18/2009
Exercise Training and Deconditions: Implications for Therapy in Mitochondrial Myopathy
Status: Enrolling
Updated: 5/18/2009
Click here to add this to my saved trials
Cortex Changes in Real/Imagined Movements in Amyotrophic Lateral Sclerosis (ALS)
Updated: 5/26/2009
Tracking Brain Changes During Real and Imagined Movements in People With ALS (Lou Gehrig's Disease) and Healthy Volunteers.
Status: Enrolling
Updated: 5/26/2009
Cortex Changes in Real/Imagined Movements in Amyotrophic Lateral Sclerosis (ALS)
Updated: 5/26/2009
Tracking Brain Changes During Real and Imagined Movements in People With ALS (Lou Gehrig's Disease) and Healthy Volunteers.
Status: Enrolling
Updated: 5/26/2009
Click here to add this to my saved trials
Effects of Strattera and Behavior Therapy on the School and Home Functioning of Elementary School Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
Updated: 6/10/2009
Effects of Strattera and Behavior Therapy on the School and Home Functioning of Elementary School Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 6/10/2009
Effects of Strattera and Behavior Therapy on the School and Home Functioning of Elementary School Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
Updated: 6/10/2009
Effects of Strattera and Behavior Therapy on the School and Home Functioning of Elementary School Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 6/10/2009
Click here to add this to my saved trials
Treatment Routes for Exploring Agitation
Updated: 7/1/2009
Treatment of Agitation in the Nursing Home
Status: Enrolling
Updated: 7/1/2009
Treatment Routes for Exploring Agitation
Updated: 7/1/2009
Treatment of Agitation in the Nursing Home
Status: Enrolling
Updated: 7/1/2009
Click here to add this to my saved trials
Study of Fluconazole in Children With Autism Spectrum Disorder
Updated: 7/8/2009
A Double-Blind, Placebo-Controlled Study of the Efficacy of Fluconazole as a Treatment for Autism Spectrum Disorder
Status: Enrolling
Updated: 7/8/2009
Study of Fluconazole in Children With Autism Spectrum Disorder
Updated: 7/8/2009
A Double-Blind, Placebo-Controlled Study of the Efficacy of Fluconazole as a Treatment for Autism Spectrum Disorder
Status: Enrolling
Updated: 7/8/2009
Click here to add this to my saved trials
Study of Fluconazole in Children With Autism Spectrum Disorder
Updated: 7/8/2009
A Double-Blind, Placebo-Controlled Study of the Efficacy of Fluconazole as a Treatment for Autism Spectrum Disorder
Status: Enrolling
Updated: 7/8/2009
Study of Fluconazole in Children With Autism Spectrum Disorder
Updated: 7/8/2009
A Double-Blind, Placebo-Controlled Study of the Efficacy of Fluconazole as a Treatment for Autism Spectrum Disorder
Status: Enrolling
Updated: 7/8/2009
Click here to add this to my saved trials
Study of Fluconazole in Children With Autism Spectrum Disorder
Updated: 7/8/2009
A Double-Blind, Placebo-Controlled Study of the Efficacy of Fluconazole as a Treatment for Autism Spectrum Disorder
Status: Enrolling
Updated: 7/8/2009
Study of Fluconazole in Children With Autism Spectrum Disorder
Updated: 7/8/2009
A Double-Blind, Placebo-Controlled Study of the Efficacy of Fluconazole as a Treatment for Autism Spectrum Disorder
Status: Enrolling
Updated: 7/8/2009
Click here to add this to my saved trials
Phase II High-Dose Cyclophosphamide for Multiple Sclerosis
Updated: 7/21/2009
Phase II Trial of High-dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis
Status: Enrolling
Updated: 7/21/2009
Phase II High-Dose Cyclophosphamide for Multiple Sclerosis
Updated: 7/21/2009
Phase II Trial of High-dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis
Status: Enrolling
Updated: 7/21/2009
Click here to add this to my saved trials
A Pilot Study of Ultra Rapid Opioid Rotation and Titration of Oxymorphone
Updated: 7/23/2009
A Pilot Study of Ultra Rapid Opioid Rotation and Titration of Oxymorphone
Status: Enrolling
Updated: 7/23/2009
A Pilot Study of Ultra Rapid Opioid Rotation and Titration of Oxymorphone
Updated: 7/23/2009
A Pilot Study of Ultra Rapid Opioid Rotation and Titration of Oxymorphone
Status: Enrolling
Updated: 7/23/2009
Click here to add this to my saved trials
Study of Generalized Movements for Early Prediction of Cerebral Palsy
Updated: 8/3/2009
Early Prediction of Cerebral Palsy in Preterm Infants and Term Infants Using Detection of Generalized Movements
Status: Enrolling
Updated: 8/3/2009
Study of Generalized Movements for Early Prediction of Cerebral Palsy
Updated: 8/3/2009
Early Prediction of Cerebral Palsy in Preterm Infants and Term Infants Using Detection of Generalized Movements
Status: Enrolling
Updated: 8/3/2009
Click here to add this to my saved trials
Neurophysiology and Anatomy of Severe Intraventricular Hemorrhage (IVH)
Updated: 8/11/2009
Influence of Altered Cerebral Spinal Fluid and Arterial Flows on Cerebral Processing Functions in Premature Infants With Severe Intraventricular Hemorrhage
Status: Enrolling
Updated: 8/11/2009
Neurophysiology and Anatomy of Severe Intraventricular Hemorrhage (IVH)
Updated: 8/11/2009
Influence of Altered Cerebral Spinal Fluid and Arterial Flows on Cerebral Processing Functions in Premature Infants With Severe Intraventricular Hemorrhage
Status: Enrolling
Updated: 8/11/2009
Click here to add this to my saved trials
Body Composition Assessment in Spinal Cord Injury
Updated: 8/11/2009
Body Composition Assessment in Spinal Cord Injury
Status: Enrolling
Updated: 8/11/2009
Body Composition Assessment in Spinal Cord Injury
Updated: 8/11/2009
Body Composition Assessment in Spinal Cord Injury
Status: Enrolling
Updated: 8/11/2009
Click here to add this to my saved trials
Safety of Polyphenon E in Multiple Sclerosis Pilot Study
Updated: 8/13/2009
Safety and Neuroprotective Effects of Polyphenon E in Multiple Sclerosis
Status: Enrolling
Updated: 8/13/2009
Safety of Polyphenon E in Multiple Sclerosis Pilot Study
Updated: 8/13/2009
Safety and Neuroprotective Effects of Polyphenon E in Multiple Sclerosis
Status: Enrolling
Updated: 8/13/2009
Click here to add this to my saved trials
Cost-Effectiveness of a Specialized Ultrasound Instrument to Diagnose Carotid Stenosis as a Way to Reduce the Risk of Stroke
Updated: 8/25/2009
New Ultrasound Instrument for Carotid Screening
Status: Enrolling
Updated: 8/25/2009
Cost-Effectiveness of a Specialized Ultrasound Instrument to Diagnose Carotid Stenosis as a Way to Reduce the Risk of Stroke
Updated: 8/25/2009
New Ultrasound Instrument for Carotid Screening
Status: Enrolling
Updated: 8/25/2009
Click here to add this to my saved trials
Effectiveness of ATMX in Treating Adolescents With ADHD and SUD
Updated: 9/2/2009
Atomoxetine in Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorder (SUD)
Status: Enrolling
Updated: 9/2/2009
Effectiveness of ATMX in Treating Adolescents With ADHD and SUD
Updated: 9/2/2009
Atomoxetine in Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorder (SUD)
Status: Enrolling
Updated: 9/2/2009
Click here to add this to my saved trials
Enhancing ADHD Driving Performance With Stimulant Medication
Updated: 9/2/2009
Enhancing ADHD Driving Performance With Stimulant Medication
Status: Enrolling
Updated: 9/2/2009
Enhancing ADHD Driving Performance With Stimulant Medication
Updated: 9/2/2009
Enhancing ADHD Driving Performance With Stimulant Medication
Status: Enrolling
Updated: 9/2/2009
Click here to add this to my saved trials
Effect of Intravenous Acetadote on Incidence of Contrast Induced Nephropathy
Updated: 9/17/2009
N-Acetylcysteine to Prevent Contrast-Induced Nephropathy in Acute Coronary Syndromes
Status: Enrolling
Updated: 9/17/2009
Effect of Intravenous Acetadote on Incidence of Contrast Induced Nephropathy
Updated: 9/17/2009
N-Acetylcysteine to Prevent Contrast-Induced Nephropathy in Acute Coronary Syndromes
Status: Enrolling
Updated: 9/17/2009
Click here to add this to my saved trials
Safety and Efficacy Study of Clevidipine to Control Hypertension in Patients Admitted With Aneurysmal Subarachnoid Hemorrhage
Updated: 9/17/2009
Clevidipine in Aneurysmal Subarachnoid Hemorrhage, A Pilot Study
Status: Enrolling
Updated: 9/17/2009
Safety and Efficacy Study of Clevidipine to Control Hypertension in Patients Admitted With Aneurysmal Subarachnoid Hemorrhage
Updated: 9/17/2009
Clevidipine in Aneurysmal Subarachnoid Hemorrhage, A Pilot Study
Status: Enrolling
Updated: 9/17/2009
Click here to add this to my saved trials
Bioavailability of Ubiquinol in Huntington Disease
Updated: 9/18/2009
Bioavailability of Ubiquinol in Huntington Disease
Status: Enrolling
Updated: 9/18/2009
Bioavailability of Ubiquinol in Huntington Disease
Updated: 9/18/2009
Bioavailability of Ubiquinol in Huntington Disease
Status: Enrolling
Updated: 9/18/2009
Click here to add this to my saved trials
Fatigue, Sleep Disorders and Endocrine Abnormalities in TBI Patients
Updated: 10/2/2009
The Relationship Between Fatigue, Sleep Disorders and Endocrine Abnormalities Following Traumatic Brain Injury
Status: Enrolling
Updated: 10/2/2009
Fatigue, Sleep Disorders and Endocrine Abnormalities in TBI Patients
Updated: 10/2/2009
The Relationship Between Fatigue, Sleep Disorders and Endocrine Abnormalities Following Traumatic Brain Injury
Status: Enrolling
Updated: 10/2/2009
Click here to add this to my saved trials
Telepharmacy Robotic Medicine Delivery Unit "TRMDU" Assessment
Updated: 11/3/2009
Evaluation of a Telepharmacy Robotic Medicine Delivery Unit in Warrior Transition Unit Patients With Traumatic Brain Injury, Post-Traumatic Stress Disorder, or Polytrauma
Status: Enrolling
Updated: 11/3/2009
Telepharmacy Robotic Medicine Delivery Unit "TRMDU" Assessment
Updated: 11/3/2009
Evaluation of a Telepharmacy Robotic Medicine Delivery Unit in Warrior Transition Unit Patients With Traumatic Brain Injury, Post-Traumatic Stress Disorder, or Polytrauma
Status: Enrolling
Updated: 11/3/2009
Click here to add this to my saved trials
Telepharmacy Robotic Medicine Delivery Unit "TRMDU" Assessment
Updated: 11/3/2009
Evaluation of a Telepharmacy Robotic Medicine Delivery Unit in Warrior Transition Unit Patients With Traumatic Brain Injury, Post-Traumatic Stress Disorder, or Polytrauma
Status: Enrolling
Updated: 11/3/2009
Telepharmacy Robotic Medicine Delivery Unit "TRMDU" Assessment
Updated: 11/3/2009
Evaluation of a Telepharmacy Robotic Medicine Delivery Unit in Warrior Transition Unit Patients With Traumatic Brain Injury, Post-Traumatic Stress Disorder, or Polytrauma
Status: Enrolling
Updated: 11/3/2009
Click here to add this to my saved trials
Telepharmacy Robotic Medicine Delivery Unit "TRMDU" Assessment
Updated: 11/3/2009
Evaluation of a Telepharmacy Robotic Medicine Delivery Unit in Warrior Transition Unit Patients With Traumatic Brain Injury, Post-Traumatic Stress Disorder, or Polytrauma
Status: Enrolling
Updated: 11/3/2009
Telepharmacy Robotic Medicine Delivery Unit "TRMDU" Assessment
Updated: 11/3/2009
Evaluation of a Telepharmacy Robotic Medicine Delivery Unit in Warrior Transition Unit Patients With Traumatic Brain Injury, Post-Traumatic Stress Disorder, or Polytrauma
Status: Enrolling
Updated: 11/3/2009
Click here to add this to my saved trials
Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia
Updated: 11/12/2009
Huperzine-A for Cognitive Dysfunction and Functional Status in Schizophrenia
Status: Enrolling
Updated: 11/12/2009
Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia
Updated: 11/12/2009
Huperzine-A for Cognitive Dysfunction and Functional Status in Schizophrenia
Status: Enrolling
Updated: 11/12/2009
Click here to add this to my saved trials
Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI)
Updated: 11/16/2009
The Delayed vs Early Enoxaparin Prophylaxis (DEEP) Study After Traumatic Brain Injury: A Randomized, Double-Blinded, Placebo Controlled Pilot Trial
Status: Enrolling
Updated: 11/16/2009
Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI)
Updated: 11/16/2009
The Delayed vs Early Enoxaparin Prophylaxis (DEEP) Study After Traumatic Brain Injury: A Randomized, Double-Blinded, Placebo Controlled Pilot Trial
Status: Enrolling
Updated: 11/16/2009
Click here to add this to my saved trials
Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI)
Updated: 11/16/2009
The Delayed vs Early Enoxaparin Prophylaxis (DEEP) Study After Traumatic Brain Injury: A Randomized, Double-Blinded, Placebo Controlled Pilot Trial
Status: Enrolling
Updated: 11/16/2009
Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI)
Updated: 11/16/2009
The Delayed vs Early Enoxaparin Prophylaxis (DEEP) Study After Traumatic Brain Injury: A Randomized, Double-Blinded, Placebo Controlled Pilot Trial
Status: Enrolling
Updated: 11/16/2009
Click here to add this to my saved trials
Double Blind, Crossover Study of Fish Oil [EPA and DHA] for Intractable Partial Seizures
Updated: 12/4/2009
Pilot Randomized Double Blind Crossover Study Of Fish Oil [Eicosapentaenoic Acid (EPA) And Docosahexaenoic Acid (DHA)] For Intractable Partial Seizures
Status: Enrolling
Updated: 12/4/2009
Double Blind, Crossover Study of Fish Oil [EPA and DHA] for Intractable Partial Seizures
Updated: 12/4/2009
Pilot Randomized Double Blind Crossover Study Of Fish Oil [Eicosapentaenoic Acid (EPA) And Docosahexaenoic Acid (DHA)] For Intractable Partial Seizures
Status: Enrolling
Updated: 12/4/2009
Click here to add this to my saved trials
Predictors of Cognitive Decline in Normal Aging
Updated: 12/10/2009
Predictors of Cognitive Decline in Normal Aging
Status: Enrolling
Updated: 12/10/2009
Predictors of Cognitive Decline in Normal Aging
Updated: 12/10/2009
Predictors of Cognitive Decline in Normal Aging
Status: Enrolling
Updated: 12/10/2009
Click here to add this to my saved trials
Exercise and Activities for Independent Living With Mild Cognitive Impairment (MCI)
Updated: 12/10/2009
Exercise & Health Promotion for MCI: A Controlled Trial
Status: Enrolling
Updated: 12/10/2009
Exercise and Activities for Independent Living With Mild Cognitive Impairment (MCI)
Updated: 12/10/2009
Exercise & Health Promotion for MCI: A Controlled Trial
Status: Enrolling
Updated: 12/10/2009
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
Updated: 12/21/2009
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
Updated: 12/21/2009
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
Updated: 12/21/2009
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
Updated: 12/21/2009
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
Updated: 12/21/2009
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
Updated: 12/21/2009
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
Updated: 12/21/2009
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
Updated: 12/21/2009
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
Updated: 12/21/2009
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
Updated: 12/21/2009
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
Updated: 12/21/2009
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
Updated: 12/21/2009
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
Updated: 12/21/2009
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
Updated: 12/21/2009
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
Updated: 12/21/2009
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
Updated: 12/21/2009
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
Updated: 12/21/2009
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
Updated: 12/21/2009
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
Updated: 12/21/2009
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
Updated: 12/21/2009
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Click here to add this to my saved trials